{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:52:28Z","timestamp":1793364748173,"version":"4.5.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00106-018-0557-7","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T15:30:50Z","timestamp":1535643050000},"page":"15-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immunologie der Polyposis nasi als Grundlage f\u00fcr eine Therapie mit Biologicals","Immunology of chronic rhinosinusitis with nasal polyps as a basis for treatment with biologicals"],"prefix":"10.1007","volume":"67","author":[{"given":"L.","family":"Klimek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koennecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"557_CR1","first-page":"3","volume":"23","author":"WJ Fokkens","year":"2012","unstructured":"Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et\u00a0al (2012) European position paper on Rhinosinusitis and nasal polyps 2012. Rhinol Suppl 23:3 (preceding table of contents, 1\u2013298)","journal-title":"Rhinol Suppl"},{"issue":"9","key":"557_CR2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","volume":"66","author":"D Hastan","year":"2011","unstructured":"Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A et\u00a0al (2011) Chronic rhinosinusitis in Europe \u2013 an underestimated disease. A GA(2)LEN study. Allergy 66(9):1216\u20131223","journal-title":"Allergy."},{"issue":"1","key":"557_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00106-017-0401-5","volume":"66","author":"BA Stuck","year":"2018","unstructured":"Stuck BA, Beule A, Jobst D, Klimek L, Laudien M, Lell M et al (2018) Guideline for \u201crhinosinusitis\u201d-long version: S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery. HNO 66(1):38\u201374","journal-title":"HNO"},{"issue":"3","key":"557_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.otohns.2007.07.021","volume":"137","author":"RM Rosenfeld","year":"2007","unstructured":"Rosenfeld RM (2007) Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg 137(3):365\u2013377","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"557_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s40629-017-0048-5","volume":"27","author":"M Koennecke","year":"2018","unstructured":"Koennecke M, Klimek L, Mullol J, Gevaert P, Wollenberg B (2018) Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities. Allergo J Int 27(2):56\u201365","journal-title":"Allergo J Int"},{"issue":"16","key":"557_CR6","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.2174\/138161212800166022","volume":"18","author":"L Calus","year":"2012","unstructured":"Calus L, Van Zele T, Derycke L, Krysko O, Dutre T, Tomassen P et\u00a0al (2012) Local inflammation in chronic upper airway disease. Curr Pharm Des 18(16):2336\u20132346","journal-title":"Curr Pharm Des"},{"issue":"6","key":"557_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/ar2843","volume":"11","author":"F Annunziato","year":"2009","unstructured":"Annunziato F, Romagnani S (2009) Heterogeneity of human effector CD4+ T cells. Arthritis Res Ther 11(6):257","journal-title":"Arthritis Res Ther"},{"key":"557_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/B978-0-12-387664-5.00005-4","volume":"109","author":"B Zygmunt","year":"2011","unstructured":"Zygmunt B, Veldhoen M (2011) T helper cell differentiation more than just cytokines. Adv Immunol 109:159\u2013196","journal-title":"Adv Immunol"},{"issue":"2","key":"557_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1378\/chest.11-1730","volume":"141","author":"D Kaur","year":"2012","unstructured":"Kaur D, Brightling C (2012) OX40\/OX40 ligand interactions in T\u2011cell regulation and asthma. Chest 141(2):494\u2013499","journal-title":"Chest"},{"issue":"2","key":"557_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.191.2.201","volume":"191","author":"P Lane","year":"2000","unstructured":"Lane P (2000) Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J\u00a0Exp Med 191(2):201\u2013206","journal-title":"J Exp Med"},{"issue":"7","key":"557_CR11","doi-asserted-by":"publisher","first-page":"e11450","DOI":"10.1371\/journal.pone.0011450","volume":"5","author":"DA Plager","year":"2010","unstructured":"Plager DA, Kahl JC, Asmann YW, Nilson AE, Pallanch JF, Friedman O et\u00a0al (2010) Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS ONE 5(7):e11450","journal-title":"PLoS ONE"},{"issue":"11","key":"557_CR12","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","volume":"61","author":"T Van Zele","year":"2006","unstructured":"Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P et\u00a0al (2006) Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61(11):1280\u20131289","journal-title":"Allergy."},{"issue":"6417","key":"557_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/362245a0","volume":"362","author":"M Kopf","year":"1993","unstructured":"Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G (1993) Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362(6417):245\u2013248","journal-title":"Nature"},{"issue":"5","key":"557_CR14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S1074-7613(00)80671-8","volume":"9","author":"W Ouyang","year":"1998","unstructured":"Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC et al (1998) Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9(5):745\u2013755","journal-title":"Immunity"},{"issue":"6","key":"557_CR15","doi-asserted-by":"publisher","first-page":"e97581","DOI":"10.1371\/journal.pone.0097581","volume":"9","author":"L Derycke","year":"2014","unstructured":"Derycke L, Eyerich S, Van Crombruggen K, Perez-Novo C, Holtappels G, Deruyck N et al (2014) Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps. PLoS ONE 9(6):e97581","journal-title":"PLoS ONE"},{"issue":"3","key":"557_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00405-005-1031-1","volume":"263","author":"A Danielsen","year":"2006","unstructured":"Danielsen A, Tynning T, Brokstad KA, Olofsson J, Davidsson A (2006) Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum. Eur Arch Otorhinolaryngol 263(3):282\u2013289","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"8","key":"557_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s13238-011-1083-5","volume":"2","author":"Z Li","year":"2011","unstructured":"Li Z, Zhang Y, Sun B (2011) Current understanding of Th2 cell differentiation and function. Protein Cell 2(8):604\u2013611","journal-title":"Protein Cell"},{"issue":"6","key":"557_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jaci.2010.08.031","volume":"126","author":"C Prussin","year":"2010","unstructured":"Prussin C, Yin Y, Upadhyaya B (2010) T(H)2 heterogeneity: does function follow form? J\u00a0Allergy Clin Immunol 126(6):1094\u20131098","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Pt 1","key":"557_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","volume":"99","author":"C Bachert","year":"1997","unstructured":"Bachert C, Wagenmann M, Hauser U, Rudack C (1997) IL-5 synthesis is upregulated in human nasal polyp tissue. J\u00a0Allergy Clin Immunol 99(6 Pt 1):837\u2013842","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"557_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2500\/105065800781329573","volume":"14","author":"C Bachert","year":"2000","unstructured":"Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P (2000) Nasal polyposis: from cytokines to growth. Am J Rhinol 14(5):279\u2013290","journal-title":"Am J Rhinol"},{"issue":"6","key":"557_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1074-7613(01)00151-0","volume":"14","author":"SM Hurst","year":"2001","unstructured":"Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N et al (2001) Il-6 and its soluble receptor orchestrate a\u00a0temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14(6):705\u2013714","journal-title":"Immunity"},{"issue":"6","key":"557_CR22","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.4049\/jimmunol.175.6.3463","volume":"175","author":"SA Jones","year":"2005","unstructured":"Jones SA (2005) Directing transition from innate to acquired immunity: defining a\u00a0role for IL-6. J\u00a0Immunol 175(6):3463\u20133468","journal-title":"J Immunol"},{"issue":"1","key":"557_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1471-4906(02)00013-3","volume":"24","author":"G Kaplanski","year":"2003","unstructured":"Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C (2003) IL-6: a\u00a0regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 24(1):25\u201329","journal-title":"Trends Immunol"},{"issue":"2","key":"557_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jaci.2009.10.072","volume":"125","author":"AT Peters","year":"2010","unstructured":"Peters AT, Kato A, Zhang N, Conley DB, Suh L, Tancowny B et al (2010) Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J\u00a0Allergy Clin Immunol 125(2):397\u2013403","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"557_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","volume":"137","author":"P Tomassen","year":"2016","unstructured":"Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H et\u00a0al (2016) Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J\u00a0Allergy Clin Immunol 137(5):1449\u20131456","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"557_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1398-9995.2011.02706.x","volume":"67","author":"A Keswani","year":"2012","unstructured":"Keswani A, Chustz RT, Suh L, Carter R, Peters AT, Tan BK et al (2012) Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps. Allergy 67(1):25\u201332","journal-title":"Allergy"},{"issue":"10","key":"557_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/alr.21792","volume":"6","author":"JS Cho","year":"2016","unstructured":"Cho JS, Kim JA, Park JH, Park IH, Han IH, Lee HM (2016) Toll-like receptor 4\u2011mediated expression of interleukin-32 via the c\u2011Jun N\u2011terminal kinase\/protein kinase B\/cyclic adenosine monophosphate response element binding protein pathway in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 6(10):1020\u20131028","journal-title":"Int Forum Allergy Rhinol"},{"issue":"7","key":"557_CR28","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.4049\/jimmunol.0901913","volume":"184","author":"X Bai","year":"2010","unstructured":"Bai X, Kim SH, Azam T, McGibney MT, Huang H, Dinarello CA et al (2010) IL-32 is a\u00a0host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J\u00a0Immunol 184(7):3830\u20133840","journal-title":"J Immunol"},{"issue":"Suppl 3","key":"557_CR29","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","volume":"65","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA, Kim SH (2006) IL-32, a\u00a0novel cytokine with a\u00a0possible role in disease. Ann Rheum Dis 65(Suppl 3):iii61\u2013iii64","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"557_CR30","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA (2005) Interleukin-32: a\u00a0cytokine and inducer of TNFalpha. Immunity 22(1):131\u2013142","journal-title":"Immunity"},{"issue":"9","key":"557_CR31","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.4049\/jimmunol.0902667","volume":"185","author":"W Li","year":"2010","unstructured":"Li W, Sun W, Liu L, Yang F, Li Y, Chen Y et al (2010) IL-32: a\u00a0host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J\u00a0Immunol 185(9):5056\u20135065","journal-title":"J Immunol"},{"issue":"8","key":"557_CR32","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","volume":"3","author":"MG Netea","year":"2006","unstructured":"Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D et al (2006) Mycobacterium tuberculosis induces interleukin-32 production through a\u00a0caspase- 1\/IL-18\/interferon-gamma-dependent mechanism. Plos Med 3(8):e277","journal-title":"Plos Med"},{"issue":"1","key":"557_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","volume":"181","author":"MF Nold","year":"2008","unstructured":"Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH et al (2008) Endogenous IL-32 controls cytokine and HIV-1 production. J\u00a0Immunol 181(1):557\u2013565","journal-title":"J Immunol"},{"issue":"9","key":"557_CR34","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","volume":"178","author":"F Calabrese","year":"2008","unstructured":"Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P et al (2008) IL-32, a\u00a0novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178(9):894\u2013901","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"557_CR35","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jaci.2010.01.016","volume":"125","author":"N Meyer","year":"2010","unstructured":"Meyer N, Zimmermann M, Burgler S, Bassin C, Woehrl S, Moritz K et al (2010) IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J\u00a0Allergy Clin Immunol 125(4):858\u2013865","journal-title":"J Allergy Clin Immunol"},{"key":"557_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.biochi.2014.01.013","volume":"101","author":"JW Kang","year":"2014","unstructured":"Kang JW, Park YS, Lee DH, Kim MS, Bak Y, Ham SY et al (2014) Interaction network mapping among IL-32 isoforms. Biochimie 101:248\u2013251","journal-title":"Biochimie"},{"issue":"1","key":"557_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/MOO.0b013e32835bc3f9","volume":"21","author":"D Chin","year":"2013","unstructured":"Chin D, Harvey RJ (2013) Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment. Curr Opin Otolaryngol Head Neck Surg 21(1):23\u201330","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5","key":"557_CR38","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.jaci.2015.10.019","volume":"137","author":"EP Lam","year":"2016","unstructured":"Lam EP, Kariyawasam HH, Rana BM, Durham SR, McKenzie AN, Powell N et al (2016) IL-25\/IL-33-responsive TH2 cells characterize nasal polyps with a\u00a0default TH17 signature in nasal mucosa. J\u00a0Allergy Clin Immunol 137(5):1514\u20131524","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"557_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.alit.2014.12.006","volume":"64","author":"A Kato","year":"2015","unstructured":"Kato A (2015) Immunopathology of chronic rhinosinusitis. Allergol Int 64(2):121\u2013130","journal-title":"Allergol Int"},{"issue":"8","key":"557_CR40","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1084\/jem.20070406","volume":"204","author":"YH Wang","year":"2007","unstructured":"Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S et al (2007) IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J\u00a0Exp Med 204(8):1837\u20131847","journal-title":"J Exp Med"},{"issue":"6","key":"557_CR41","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jaci.2015.01.003","volume":"135","author":"HW Shin","year":"2015","unstructured":"Shin HW, Kim DK, Park MH, Eun KM, Lee M, So D et al (2015) IL-25 as a\u00a0novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. J\u00a0Allergy Clin Immunol 135(6):1476\u20131485","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"557_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4168\/aair.2011.3.3.186","volume":"3","author":"S Kimura","year":"2011","unstructured":"Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T et\u00a0al (2011) Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res 3(3):186\u2013193","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"557_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MAJ.0b013e3181f20489","volume":"341","author":"T Liu","year":"2011","unstructured":"Liu T, Li TL, Zhao F, Xie C, Liu AM, Chen X et\u00a0al (2011) Role of thymic stromal lymphopoietin in the pathogenesis of nasal polyposis. Am J Med Sci 341(1):40\u201347","journal-title":"Am J Med Sci"},{"issue":"3","key":"557_CR44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","volume":"132","author":"DR Nagarkar","year":"2013","unstructured":"Nagarkar DR, Poposki JA, Tan BK, Comeau MR, Peters AT, Hulse KE et\u00a0al (2013) Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J\u00a0Allergy Clin Immunol 132(3):593\u2013600","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"557_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jaci.2012.04.019","volume":"130","author":"DR Nagarkar","year":"2012","unstructured":"Nagarkar DR, Poposki JA, Comeau MR, Biyasheva A, Avila PC, Schleimer RP et al (2012) Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin. J\u00a0Allergy Clin Immunol 130(1):225\u2013232","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"557_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2500\/ajra.2010.24.3446","volume":"24","author":"DD Reh","year":"2010","unstructured":"Reh DD, Wang Y, Ramanathan M Jr., Lane AP (2010) Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33. Am J Rhinol Allergy 24(2):105\u2013109","journal-title":"Am J Rhinol Allergy"},{"issue":"7","key":"557_CR47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/thoraxjnl-2016-208772","volume":"72","author":"DK Kim","year":"2016","unstructured":"Kim DK, Jin HR, Eun KM, Mo JH, Cho SH, Oh S et al (2017) The role of interleukin-33 in chronic rhinosinusitis. Thorax 72(7):635\u2013645. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-208772. Epub 2016 Nov 24","journal-title":"Thorax"},{"key":"557_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend WP, Palmer G, Gabay C (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223:20\u201338","journal-title":"Immunol Rev"},{"issue":"6","key":"557_CR49","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","volume":"121","author":"WB Cherry","year":"2008","unstructured":"Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H (2008) A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J\u00a0Allergy Clin Immunol 121(6):1484\u20131490","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"557_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2500\/ajra.2009.23.3303","volume":"23","author":"R Castano","year":"2009","unstructured":"Castano R, Bosse Y, Endam LM, Desrosiers M (2009) Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis. Am J Rhinol Allergy 23(4):377\u2013384","journal-title":"Am J Rhinol Allergy"},{"issue":"11","key":"557_CR51","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2104","volume":"12","author":"JM Mjosberg","year":"2011","unstructured":"Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B et al (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12(11):1055\u20131062","journal-title":"Nat Immunol"},{"issue":"5","key":"557_CR52","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jaci.2016.09.006","volume":"138","author":"ML Robinette","year":"2016","unstructured":"Robinette ML, Colonna M (2016) Immune modules shared by innate lymphoid cells and T cells. J\u00a0Allergy Clin Immunol 138(5):1243\u20131251","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"557_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jaci.2011.10.036","volume":"129","author":"HY Kim","year":"2012","unstructured":"Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P et al (2012) Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J\u00a0Allergy Clin Immunol 129(1):216\u2013227","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"557_CR54","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jaci.2016.09.011","volume":"138","author":"H Morita","year":"2016","unstructured":"Morita H, Moro K, Koyasu S (2016) Innate lymphoid cells in allergic and nonallergic inflammation. J\u00a0Allergy Clin Immunol 138(5):1253\u20131264","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"557_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/alr.21417","volume":"5","author":"J Ho","year":"2015","unstructured":"Ho J, Bailey M, Zaunders J, Mrad N, Sacks R, Sewell W et\u00a0al (2015) Cellular comparison of sinus mucosa vs polyp tissue from a\u00a0single sinus cavity in chronic rhinosinusitis. Int Forum Allergy Rhinol 5(1):14\u201327","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"557_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cea.12462","volume":"45","author":"J Ho","year":"2015","unstructured":"Ho J, Bailey M, Zaunders J, Mrad N, Sacks R, Sewell W et\u00a0al (2015) Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin Exp Allergy 45(2):394\u2013403","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"557_CR57","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0091-6749(96)70126-4","volume":"98","author":"LA Beck","year":"1996","unstructured":"Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA et\u00a0al (1996) Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J\u00a0Allergy Clin Immunol 98(4):766\u2013780","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"557_CR58","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3109\/00016489609137897","volume":"116","author":"A Davidsson","year":"1996","unstructured":"Davidsson A, Danielsen A, Viale G, Olofsson J, Dell\u2019Orto P, Pellegrini C et al (1996) Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease. Clinical relevance and relation to allergy. Acta Otolaryngol 116(4):604\u2013610","journal-title":"Acta Otolaryngol."},{"issue":"5 Pt 1","key":"557_CR59","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/000348949810700510","volume":"107","author":"JS Allen","year":"1998","unstructured":"Allen JS, Eisma R, LaFreniere D, Leonard G, Kreutzer D (1998) Characterization of the eosinophil chemokine RANTES in nasal polyps. Ann Otol Rhinol Laryngol 107(5 Pt 1):416\u2013420","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"557_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/194589240501900103","volume":"19","author":"JE Meyer","year":"2005","unstructured":"Meyer JE, Bartels J, Gorogh T, Sticherling M, Rudack C, Ross DA et\u00a0al (2005) The role of RANTES in nasal polyposis. Am J Rhinol 19(1):15\u201320","journal-title":"Am J Rhinol"},{"issue":"2","key":"557_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/194589240501900202","volume":"19","author":"YS Chen","year":"2005","unstructured":"Chen YS, Arab SF, Westhofen M, Lorenzen J (2005) Expression of interleukin-5, interleukin-8, and interleukin-10 mRNA in the osteomeatal complex in nasal polyposis. Am J Rhinol 19(2):117\u2013123","journal-title":"Am J Rhinol"},{"issue":"10","key":"557_CR62","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1398-9995.2005.00888.x","volume":"60","author":"K Kostamo","year":"2005","unstructured":"Kostamo K, Sorsa T, Leino M, Tervahartiala T, Alenius H, Richardson M et al (2005) In vivo relationship between collagenase-2 and interleukin-8 but not tumour necrosis factor-alpha in chronic rhinosinusitis with nasal polyposis. Allergy 60(10):1275\u20131279","journal-title":"Allergy."},{"issue":"6","key":"557_CR63","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.biopha.2004.11.010","volume":"59","author":"MC Scavuzzo","year":"2005","unstructured":"Scavuzzo MC, Fattori B, Ruffoli R, Rocchi V, Carpi A, Berni R et al (2005) Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis. Biomed Pharmacother 59(6):323\u2013329","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"557_CR64","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","volume":"138","author":"X Wang","year":"2016","unstructured":"Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H et\u00a0al (2016) Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J\u00a0Allergy Clin Immunol 138(5):1344\u20131353","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"557_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaci.2011.03.017","volume":"128","author":"JA Poposki","year":"2011","unstructured":"Poposki JA, Uzzaman A, Nagarkar DR, Chustz RT, Peters AT, Suh LA et\u00a0al (2011) Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps. J\u00a0Allergy Clin Immunol 128(1):73\u201381","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"557_CR66","first-page":"209","volume":"51","author":"C Bachert","year":"1997","unstructured":"Bachert C, Van Cauwenberge PB (1997) Inflammatory mechanisms in chronic sinusitis. Acta Otorhinolaryngol Belg 51(4):209\u2013217","journal-title":"Acta Otorhinolaryngol Belg"},{"issue":"3","key":"557_CR67","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12223-012-0194-6","volume":"58","author":"P Fundova","year":"2013","unstructured":"Fundova P, Funda DP, Kovar D, Holy R, Navara M, Tlaskalova-Hogenova H (2013) Increased expression of chemokine receptors CCR1 and CCR3 in nasal polyps: molecular basis for recruitment of the granulocyte infiltrate. Folia Microbiol (praha) 58(3):219\u2013224","journal-title":"Folia Microbiol (praha)"},{"issue":"7","key":"557_CR68","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.185.7.1163","volume":"185","author":"VP Patel","year":"1997","unstructured":"Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T et al (1997) Molecular and functional characterization of two novel human C\u2011C chemokines as inhibitors of two distinct classes of myeloid progenitors. J\u00a0Exp Med 185(7):1163\u20131172","journal-title":"J Exp Med"},{"issue":"7","key":"557_CR69","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.4049\/jimmunol.178.7.4335","volume":"178","author":"H Novak","year":"2007","unstructured":"Novak H, Muller A, Harrer N, Gunther C, Carballido JM, Woisetschlager M (2007) CCL23 expression is induced by IL-4 in a\u00a0STAT6-dependent fashion. J\u00a0Immunol 178(7):4335\u20134341","journal-title":"J Immunol"},{"issue":"1","key":"557_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2011.08.021","volume":"129","author":"S Peterson","year":"2012","unstructured":"Peterson S, Poposki JA, Nagarkar DR, Chustz RT, Peters AT, Suh LA et\u00a0al (2012) Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps. J\u00a0Allergy Clin Immunol 129(1):119\u2013127","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"557_CR71","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1084\/jem.20130240","volume":"210","author":"SA Islam","year":"2013","unstructured":"Islam SA, Ling MF, Leung J, Shreffler WG, Luster AD (2013) Identification of human CCR8 as a\u00a0CCL18 receptor. J\u00a0Exp Med 210(10):1889\u20131898","journal-title":"J Exp Med"},{"issue":"6","key":"557_CR72","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jaci.2008.03.002","volume":"121","author":"A Kato","year":"2008","unstructured":"Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R et al (2008) Evidence of a\u00a0role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J\u00a0Allergy Clin Immunol 121(6):1385\u20131392","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"557_CR73","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1398-9995.2006.01132.x","volume":"61","author":"D Polzehl","year":"2006","unstructured":"Polzehl D, Moeller P, Riechelmann H, Perner S (2006) Distinct features of chronic rhinosinusitis with and without nasal polyps. Allergy 61(11):1275\u20131279","journal-title":"Allergy."},{"issue":"1","key":"557_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2500\/ajra.2010.24.3386","volume":"24","author":"M Patadia","year":"2010","unstructured":"Patadia M, Dixon J, Conley D, Chandra R, Peters A, Suh LA et al (2010) Evaluation of the presence of B\u2011cell attractant chemokines in chronic rhinosinusitis. Am J Rhinol Allergy 24(1):11\u201316","journal-title":"Am J Rhinol Allergy"},{"issue":"22","key":"557_CR75","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","volume":"370","author":"GM Gauvreau","year":"2014","unstructured":"Gauvreau GM, O\u2019Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J et al (2014) Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N\u00a0Engl J Med 370(22):2102\u20132110","journal-title":"N Engl J Med"},{"issue":"25","key":"557_CR76","first-page":"2434","volume":"371","author":"EH Bel","year":"2014","unstructured":"Bel EH, Ortega HG, Pavord ID (2014) Glucocorticoids and mepolizumab in eosinophilic asthma. N\u00a0Engl J Med 371(25):2434","journal-title":"N Engl J Med"},{"issue":"26","key":"557_CR77","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","volume":"368","author":"S Wenzel","year":"2013","unstructured":"Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F et\u00a0al (2013) Dupilumab in persistent asthma with elevated eosinophil levels. N\u00a0Engl J Med 368(26):2455\u20132466","journal-title":"N Engl J Med"},{"issue":"3","key":"557_CR78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1586\/1744666X.2015.1010517","volume":"11","author":"B Pauwels","year":"2015","unstructured":"Pauwels B, Jonstam K, Bachert C (2015) Emerging biologics for the treatment of chronic rhinosinusitis. Expert Rev Clin Immunol 11(3):349\u2013361","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"557_CR79","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1067\/mai.2001.117880","volume":"108","author":"W Busse","year":"2001","unstructured":"Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD et al (2001) Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J\u00a0Allergy Clin Immunol 108(2):184\u2013190","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"557_CR80","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","volume":"136","author":"C Bachert","year":"2015","unstructured":"Bachert C, Zhang L, Gevaert P (2015) Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis. J\u00a0Allergy Clin Immunol 136(6):1431\u20131440","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"557_CR81","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","volume":"126","author":"C Bachert","year":"2010","unstructured":"Bachert C, Zhang N, Holtappels G, De Lobel L, van Cauwenberge P, Liu S et al (2010) Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J\u00a0Allergy Clin Immunol 126(5):962\u2013968","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"557_CR82","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11882-014-0440-x","volume":"14","author":"E Lehrer","year":"2014","unstructured":"Lehrer E, Mullol J, Agredo F, Alobid I (2014) Management of chronic rhinosinusitis in asthma patients: is there still a\u00a0debate? Curr Allergy Asthma Rep 14(6):440","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"557_CR83","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2500\/ajra.2014.28.4033","volume":"28","author":"T Van Zele","year":"2014","unstructured":"Van Zele T, Holtappels G, Gevaert P, Bachert C (2014) Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 28(3):192\u2013198","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"557_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jaci.2007.09.036","volume":"121","author":"SA Grundmann","year":"2008","unstructured":"Grundmann SA, Hemfort PB, Luger TA, Brehler R (2008) Anti-IgE (omalizumab): a\u00a0new therapeutic approach for chronic rhinosinusitis. J\u00a0Allergy Clin Immunol 121(1):257\u2013258","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"557_CR85","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1365-2222.2005.02191.x","volume":"35","author":"ST Holgate","year":"2005","unstructured":"Holgate ST, Djukanovic R, Casale T, Bousquet J (2005) Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy 35(4):408\u2013416","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"557_CR86","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4193\/Rhino09.144","volume":"48","author":"JM Pinto","year":"2010","unstructured":"Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM (2010) A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology 48(3):318\u2013324","journal-title":"Rhinology"},{"issue":"8","key":"557_CR87","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/thoraxjnl-2017-210017","volume":"73","author":"MDC Vennera","year":"2017","unstructured":"Vennera MDC, Sabadell C, Picado C, Spanish Omalizumab R (2017) Duration of the efficacy of omalizumab after treatment discontinuation in \u2018real life\u2019 severe asthma. Thorax 73(8):782\u2013784. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-210017. Epub 2017 Oct 27","journal-title":"Thorax"},{"issue":"1","key":"557_CR88","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","volume":"131","author":"P Gevaert","year":"2013","unstructured":"Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W et\u00a0al (2013) Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J\u00a0Allergy Clin Immunol 131(1):110\u2013116","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"557_CR89","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1097\/HJH.0b013e3283546719","volume":"30","author":"FJ Felix-Redondo","year":"2012","unstructured":"Felix-Redondo FJ, Fernandez-Berges D, Calderon A, Consuegra-Sanchez L, Lozano L, Barrios V (2012) Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study. J\u00a0Hypertens 30(7):1460\u20131467","journal-title":"J Hypertens"},{"issue":"4","key":"557_CR90","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jaci.2011.11.019","volume":"129","author":"MA Calderon","year":"2012","unstructured":"Calderon MA, Cox L, Casale TB, Moingeon P, Demoly P (2012) Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J\u00a0Allergy Clin Immunol 129(4):929\u2013934","journal-title":"J Allergy Clin Immunol"},{"key":"557_CR91","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-4615-5855-2_25","volume":"409","author":"R Valenta","year":"1996","unstructured":"Valenta R, Laffer S, Vrtala S, Gronlund H, Elfman L, Sperr WR et\u00a0al (1996) Recombinant allergens. Steps on the way to diagnosis and therapy of type I allergy. Adv Exp Med Biol 409:185\u2013196","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"557_CR92","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jaci.2016.02.027","volume":"138","author":"GM Gauvreau","year":"2016","unstructured":"Gauvreau GM, Arm JP, Boulet LP, Leigh R, Cockcroft DW, Davis BE et al (2016) Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses. J\u00a0Allergy Clin Immunol 138(4):1051\u20131059","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"557_CR93","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/cea.12400","volume":"44","author":"JP Arm","year":"2014","unstructured":"Arm JP, Bottoli I, Skerjanec A, Floch D, Groenewegen A, Maahs S et al (2014) Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a\u00a0novel high-affinity anti-IgE antibody, in atopic subjects. Clin Exp Allergy 44(11):1371\u20131385","journal-title":"Clin Exp Allergy"},{"issue":"243","key":"557_CR94","doi-asserted-by":"publisher","first-page":"243ra85","DOI":"10.1126\/scitranslmed.3008961","volume":"6","author":"GM Gauvreau","year":"2014","unstructured":"Gauvreau GM, Harris JM, Boulet LP, Scheerens H, Fitzgerald JM, Putnam WS et al (2014) Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production. Sci Transl Med 6(243):243ra85","journal-title":"Sci Transl Med"},{"issue":"6","key":"557_CR95","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1398-9995.2005.00790.x","volume":"60","author":"CJ Corrigan","year":"2005","unstructured":"Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A (2005) Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy 60(6):801\u2013807","journal-title":"Allergy"},{"issue":"11","key":"557_CR96","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","volume":"176","author":"P Flood-Page","year":"2007","unstructured":"Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L et al (2007) A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 176(11):1062\u20131071","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"557_CR97","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","volume":"167","author":"PT Flood-Page","year":"2003","unstructured":"Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS (2003) Eosinophil\u2019s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167(2):199\u2013204","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"557_CR98","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","volume":"371","author":"EH Bel","year":"2014","unstructured":"Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW et al (2014) Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N\u00a0Engl J Med 371(13):1189\u20131197","journal-title":"N Engl J Med"},{"issue":"5","key":"557_CR99","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","volume":"118","author":"P Gevaert","year":"2006","unstructured":"Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T et al (2006) Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J\u00a0Allergy Clin Immunol 118(5):1133\u20131141","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"557_CR100","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","volume":"128","author":"P Gevaert","year":"2011","unstructured":"Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F et al (2011) Mepolizumab, a\u00a0humanized anti-IL-5 mAb, as a\u00a0treatment option for severe nasal polyposis. J\u00a0Allergy Clin Immunol 128(5):989\u2013995","journal-title":"J Allergy Clin Immunol"},{"key":"557_CR101","unstructured":"Mepolizumab in Nasal Polyposis. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01362244."},{"key":"557_CR102","unstructured":"Effect of Mepolizumab in Severe Bilateral Nasal Polyps. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03085797."},{"issue":"5","key":"557_CR103","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","volume":"3","author":"M Castro","year":"2015","unstructured":"Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P et al (2015) Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med 3(5):355\u2013366","journal-title":"Lancet Respir Med"},{"issue":"10","key":"557_CR104","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","volume":"184","author":"M Castro","year":"2011","unstructured":"Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, Young J et al (2011) Reslizumab for poorly controlled, eosinophilic asthma: a\u00a0randomized, placebo-controlled study. Am J Respir Crit Care Med 184(10):1125\u20131132","journal-title":"Am J Respir Crit Care Med"},{"key":"557_CR105","unstructured":"Study of Chronic Rhinosinusitis Symptoms in Asthma Patients Undergoing Treatment With Reslizumab. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03369574."},{"issue":"6","key":"557_CR106","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","volume":"125","author":"R Kolbeck","year":"2010","unstructured":"Kolbeck R, Kozhich A, Koike M, Peng L, Andersson CK, Damschroder MM et al (2010) MEDI-563, a\u00a0humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J\u00a0Allergy Clin Immunol 125(6):1344\u20131353","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"557_CR107","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11882-013-0379-3","volume":"13","author":"R Berair","year":"2013","unstructured":"Berair R, Pavord ID (2013) Rationale and clinical results of inhibiting interleukin-5 for the treatment of severe asthma. Curr Allergy Asthma Rep 13(5):469\u2013476","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"557_CR108","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaci.2013.05.020","volume":"132","author":"M Laviolette","year":"2013","unstructured":"Laviolette M, Gossage DL, Gauvreau G, Leigh R, Olivenstein R, Katial R et\u00a0al (2013) Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J\u00a0Allergy Clin Immunol 132(5):1086\u20131096","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"557_CR109","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jaci.2013.12.1092","volume":"133","author":"M Mahdavinia","year":"2014","unstructured":"Mahdavinia M, Carter RG, Ocampo CJ, Stevens W, Kato A, Tan BK et\u00a0al (2014) Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity. J\u00a0Allergy Clin Immunol 133(6):1759\u20131763","journal-title":"J Allergy Clin Immunol"},{"key":"557_CR110","unstructured":"Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis (OSTRO). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03401229."},{"issue":"12","key":"557_CR111","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR et\u00a0al (2011) Lebrikizumab treatment in adults with asthma. N\u00a0Engl J Med 365(12):1088\u20131098","journal-title":"N Engl J Med"},{"issue":"4","key":"557_CR112","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaci.2014.01.002","volume":"133","author":"EH De Boever","year":"2014","unstructured":"De Boever EH, Ashman C, Cahn AP, Locantore NW, Overend P, Pouliquen IJ et al (2014) Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a\u00a0randomized trial. J\u00a0Allergy Clin Immunol 133(4):989\u2013996","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"557_CR113","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jaci.2013.03.051","volume":"132","author":"M Noonan","year":"2013","unstructured":"Noonan M, Korenblat P, Mosesova S, Scheerens H, Arron JR, Zheng Y et al (2013) Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. J\u00a0Allergy Clin Immunol 132(3):567\u2013574","journal-title":"J Allergy Clin Immunol"},{"issue":"115","key":"557_CR114","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1183\/09059180.00007609","volume":"19","author":"CK Oh","year":"2010","unstructured":"Oh CK, Geba GP, Molfino N (2010) Investigational therapeutics targeting the IL-4\/IL-13\/STAT-6 pathway for the treatment of asthma. Eur Respir Rev 19(115):46\u201354","journal-title":"Eur Respir Rev"},{"issue":"1","key":"557_CR115","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/cea.12220","volume":"44","author":"H Scheerens","year":"2014","unstructured":"Scheerens H, Arron JR, Zheng Y, Putnam WS, Erickson RW, Choy DF et\u00a0al (2014) The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clin Exp Allergy 44(1):38\u201346","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"557_CR116","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jaci.2004.07.012","volume":"114","author":"E Novembre","year":"2004","unstructured":"Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E et\u00a0al (2004) Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J\u00a0Allergy Clin Immunol 114(4):851\u2013857","journal-title":"J Allergy Clin Immunol"},{"issue":"301","key":"557_CR117","doi-asserted-by":"publisher","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","volume":"7","author":"DF Choy","year":"2015","unstructured":"Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S et\u00a0al (2015) TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 7(301):301ra129","journal-title":"Sci Transl Med"},{"issue":"8","key":"557_CR118","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.200909-1448OC","volume":"181","author":"J Corren","year":"2010","unstructured":"Corren J, Busse W, Meltzer EO, Mansfield L, Bensch G, Fahrenholz J et al (2010) A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. Am J Respir Crit Care Med 181(8):788\u2013796","journal-title":"Am J Respir Crit Care Med"},{"issue":"9596","key":"557_CR119","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(07)61600-6","volume":"370","author":"S Wenzel","year":"2007","unstructured":"Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M (2007) Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370(9596):1422\u20131431","journal-title":"Lancet"},{"issue":"10039","key":"557_CR120","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","volume":"388","author":"S Wenzel","year":"2016","unstructured":"Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B et al (2016) Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a\u00a0long-acting beta2 agonist: a\u00a0randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet 388(10039):31\u201344","journal-title":"Lancet"},{"issue":"13","key":"557_CR121","first-page":"1276","volume":"369","author":"SE Wenzel","year":"2013","unstructured":"Wenzel SE, Wang L, Pirozzi G (2013) Dupilumab in persistent asthma. N\u00a0Engl J Med 369(13):1276","journal-title":"N Engl J Med"},{"issue":"26","key":"557_CR122","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1056\/NEJMe1305426","volume":"368","author":"ME Wechsler","year":"2013","unstructured":"Wechsler ME (2013) Inhibiting interleukin-4 and interleukin-13 in difficult-to-control asthma. N\u00a0Engl J Med 368(26):2511\u20132513","journal-title":"N Engl J Med"},{"issue":"5","key":"557_CR123","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","volume":"315","author":"C Bachert","year":"2016","unstructured":"Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P et\u00a0al (2016) Effect of subcutaneous Dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal Polyposis: a randomized clinical trial. JAMA 315(5):469\u2013479","journal-title":"JAMA"},{"issue":"6","key":"557_CR124","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1016\/j.ajpath.2011.02.041","volume":"178","author":"A Barajas-Espinosa","year":"2011","unstructured":"Barajas-Espinosa A, Ochoa-Cortes F, Moos MP, Ramirez FD, Vanner SJ, Funk CD (2011) Characterization of the cysteinyl leukotriene 2 receptor in novel expression sites of the gastrointestinal tract. Am J Pathol 178(6):2682\u20132689","journal-title":"Am J Pathol"},{"issue":"24","key":"557_CR125","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.1039\/c1cc10642b","volume":"47","author":"C Stock","year":"2011","unstructured":"Stock C, Moosbauer D, Zugmann S, Simbeck T, Amereller M, Gores HJ (2011) A novel method for in situ measurement of solubility via impedance scanning quartz crystal microbalance studies. Chem Commun (camb) 47(24):6984\u20136986","journal-title":"Chem Commun (camb)"},{"issue":"1","key":"557_CR126","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cea.12235","volume":"44","author":"GM Gauvreau","year":"2014","unstructured":"Gauvreau GM, Boulet LP, Cockcroft DW, FitzGerald JM, Mayers I, Carlsten C et al (2014) OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy 44(1):29\u201337","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"557_CR127","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00106-009-1946-8","volume":"57","author":"O Pfaar","year":"2009","unstructured":"Pfaar O, Mosges R, Hormann K, Klimek L (2009) Cluster immunotherapy of persistent allergic rhinoconjunctivitis. Safety aspects of induction therapy with mite depot allergen preparations. HNO 57(11):1099\u20131105","journal-title":"HNO"},{"issue":"9","key":"557_CR128","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF03370913","volume":"151","author":"L Klimek","year":"2009","unstructured":"Klimek L, Pfaar O, Grevers G (2009) Therapeutical options in allergic rhinitis. MMW Fortschr Med 151(9):31\u201334","journal-title":"Mmw Fortschr Med"},{"issue":"3","key":"557_CR129","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/ACI.0b013e32832aef57","volume":"9","author":"O Pfaar","year":"2009","unstructured":"Pfaar O, Anders C, Klimek L (2009) Clinical outcome measures of specific immunotherapy. Curr Opin Allergy Clin Immunol 9(3):208\u2013213","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"557_CR130","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000210436","volume":"150","author":"O Pfaar","year":"2009","unstructured":"Pfaar O, Klimek L, Fischer I, Sieber J, Amoroso S, Moreno Aguilar C et\u00a0al (2009) Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens. Int Arch Allergy Immunol 150(1):102\u2013108","journal-title":"Int Arch Allergy Immunol"},{"issue":"3\u20134","key":"557_CR131","first-page":"35","volume":"139","author":"O Pfaar","year":"2009","unstructured":"Pfaar O, Raap U, Holz M, Hormann K, Klimek L (2009) Pathophysiology of itching and sneezing in allergic rhinitis. Swiss Med Wkly 139(3\u20134):35\u201340","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"557_CR132","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pharmthera.2012.06.005","volume":"135","author":"T Kiwamoto","year":"2012","unstructured":"Kiwamoto T, Kawasaki N, Paulson JC, Bochner BS (2012) Siglec-8 as a\u00a0drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol Ther 135(3):327\u2013336","journal-title":"Pharmacol Ther"},{"issue":"12","key":"557_CR133","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1182\/blood-2002-10-3058","volume":"101","author":"E Nutku","year":"2003","unstructured":"Nutku E, Aizawa H, Hudson SA, Bochner BS (2003) Ligation of Siglec-8: a\u00a0selective mechanism for induction of human eosinophil apoptosis. Blood 101(12):5014\u20135020","journal-title":"Blood"},{"issue":"1","key":"557_CR134","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cyto.2011.10.007","volume":"57","author":"HJ Na","year":"2012","unstructured":"Na HJ, Hudson SA, Bochner BS (2012) IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils. Cytokine 57(1):169\u2013174","journal-title":"Cytokine"},{"issue":"3","key":"557_CR135","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.bbrc.2005.08.202","volume":"336","author":"E Nutku","year":"2005","unstructured":"Nutku E, Hudson SA, Bochner BS (2005) Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. Biochem Biophys Res Commun 336(3):918\u2013924","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"557_CR136","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1164\/rccm.200809-1512OC","volume":"179","author":"SE Wenzel","year":"2009","unstructured":"Wenzel SE, Barnes PJ, Bleecker ER, Bousquet J, Busse W, Dahlen SE et al (2009) A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 179(7):549\u2013558","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"557_CR137","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jaci.2007.10.028","volume":"121","author":"C Brightling","year":"2008","unstructured":"Brightling C, Berry M, Amrani Y (2008) Targeting TNF-alpha: a\u00a0novel therapeutic approach for asthma. J\u00a0Allergy Clin Immunol 121(1):5\u201310 (quiz 1\u20132)","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"557_CR138","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1164\/rccm.200708-1200OC","volume":"178","author":"WW Busse","year":"2008","unstructured":"Busse WW, Israel E, Nelson HS, Baker JW, Charous BL, Young DY et\u00a0al (2008) Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a\u00a0randomized, controlled trial. Am J Respir Crit Care Med 178(10):1002\u20131008","journal-title":"Am J Respir Crit Care Med"},{"key":"557_CR139","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13601-017-0157-8","volume":"7","author":"G De Greve","year":"2017","unstructured":"De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF (2017) Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy 7:22","journal-title":"Clin Transl Allergy"},{"issue":"6","key":"557_CR140","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jaip.2017.04.024","volume":"5","author":"C Bachert","year":"2017","unstructured":"Bachert C, Gevaert P, Hellings P (2017) Biotherapeutics in chronic Rhinosinusitis with and without nasal polyps. J\u00a0Allergy Clin Immunol Pract 5(6):1512\u20131516. https:\/\/doi.org\/10.1016\/j.jaip.2017.04.024. Epub 2017 May 16","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"557_CR141","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4168\/aair.2017.9.4.299","volume":"9","author":"DW Kim","year":"2017","unstructured":"Kim DW, Cho SH (2017) Emerging Endotypes of chronic Rhinosinusitis and its application to precision medicine. Allergy Asthma Immunol Res 9(4):299\u2013306","journal-title":"Allergy Asthma Immunol Res"},{"key":"557_CR142","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40629-016-0006-7","volume":"26(1","author":"L Klimek","year":"2017","unstructured":"Klimek L, Bergmann KC, Biedermann T, Bousquet J, Hellings P, Jung K et\u00a0al (2017) Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care. Allergo J Int 26(1:16\u201324 (Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC))","journal-title":"Allergo J Int"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-018-0557-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-018-0557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-018-0557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T18:16:13Z","timestamp":1751825773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-018-0557-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1007\/s00106-018-0557-7","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]},"assertion":[{"value":"30 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Klimek, M.\u00a0Koennecke, J.\u00a0Hagemann, B.\u00a0Wollenberg und S.\u00a0Becker geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}